Basics |
Company: |
Penumbra, Inc. |
IPO Date: |
September 18, 2015 |
Sector: |
Healthcare |
Industry: |
Medical Devices |
Market Cap: |
$11.23B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$3.02 | 1.82%
|
Avg Daily Range (30 D): |
$3.89 | 1.48%
|
Avg Daily Range (90 D): |
$3.61 | 1.51%
|
Institutional Daily Volume |
Avg Daily Volume: |
.29M |
Avg Daily Volume (30 D): |
.44M |
Avg Daily Volume (90 D): |
.33M |
Trade Size |
Avg Trade Size (Sh.): |
53 |
Avg Trade Size (Sh.) (30 D): |
38 |
Avg Trade Size (Sh.) (90 D): |
35 |
Institutional Trades |
Total Inst.Trades: |
3,464 |
Avg Inst. Trade: |
$5.32M |
Avg Inst. Trade (30 D): |
$10.7M |
Avg Inst. Trade (90 D): |
$9.92M |
Avg Inst. Trade Volume: |
.03M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$6.67M |
Avg Closing Trade (30 D): |
$15.13M |
Avg Closing Trade (90 D): |
$12.55M |
Avg Closing Volume: |
35.32K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$.36
|
$.87
|
$.36
|
Diluted EPS
|
$.36
|
$.87
|
$.36
|
Revenue
|
$ 1.19B
|
$ 315.52M
|
$ 1.19B
|
Gross Profit
|
$ 755M
|
$ 210.72M
|
$ 755M
|
Net Income / Loss
|
$ 14.01M
|
$ 33.68M
|
$ 14.01M
|
Operating Income / Loss
|
$ 9.28M
|
$ 42.78M
|
$ 9.28M
|
Cost of Revenue
|
$ 439.62M
|
$ 104.8M
|
$ 439.62M
|
Net Cash Flow
|
$ 156.92M
|
$ 43.93M
|
$ 156.92M
|
PE Ratio
|
810.22
|
|
|
|